文献速递主动脉疾病外周动脉疾病

多中心pELVIS注册研究中采用髂动脉分支装置治疗孤立性髂总动脉瘤的结果

Results of the multicenter pELVIS Registry for isolated common iliac aneurysms treated by the iliac branch device.
PubMed 文献 · J Vasc Surg · 2018-07-30

基于pELVIS注册研究,2005年1月至2017年4月九家欧洲高容量血管中心共231枚髂动脉分支装置(IBD)用于207例孤立性髂总动脉瘤患者,比较无近端主动脉延长(91枚)与按说明书近端置入主动脉分叉支架(140枚)两组。技术成功率、早期再干预率、30天死亡率及60个月IBD通畅率、靶向髂内动脉通畅率、再干预率和动脉瘤相关死亡率在两组间均无显著差异。作者认为在解剖选择合适时,单枚IBD治疗孤立性髂总动脉瘤似乎是安全有效的选择。

要点

  • 单枚IBD治疗孤立性髂总动脉瘤的技术成功率为98.9%(90/91)与97.8%(137/140),两组无显著差异(P=.55)。
  • 60个月免于IBD闭塞率86%与83%(P=.69),免于靶向髂内动脉闭塞率98.3%与91.3%(P=.45)。
  • 60个月免于动脉瘤相关死亡率97.9%与100%(P=.83),两组均无显著差异。

核心结论

  • 作者认为,在解剖选择合适时,单枚IBD治疗孤立性髂总动脉瘤似乎是安全有效的治疗选择。
  • 与更广泛的术式相比,单枚IBD的主要获益为减少X线暴露、整体手术时间和对比剂用量,而不影响围手术期和长期结果。

研究设计与样本

  • pELVIS注册研究为多中心注册研究,纳入2005年1月至2017年4月九家欧洲高容量血管中心因髂分叉受累行血管内动脉瘤修复的804例患者、910枚IBD。
  • 其中231枚IBD植入207例孤立性髂总动脉瘤患者:91枚(第1组)无肾下主动脉近端延长,140枚(第2组)按说明书近端置入主动脉分叉支架。
  • 主要结局为IBD和靶向髂内动脉闭塞、I型和III型内漏、手术相关再干预及动脉瘤相关死亡。

主要发现

  • 技术成功第1组90例(98.9%)vs 第2组137例(97.8%)(P=.55)。
  • 两组总体动脉瘤相关早期再干预率分别为4.4%(4/91)和2.1%(3/140)(P=.33)。
  • 30天死亡率第1组1.1%(1例)vs 第2组0%(P=.21)。
  • 术后中位随访第1组34.1个月(范围1-108个月),第2组17.5个月(范围1-90个月)。
  • 60个月估计免于IBD闭塞率第1组86% vs 第2组83%(P=.69);60个月估计免于靶向髂内动脉闭塞率第1组98.3% vs 第2组91.3%(P=.45)。

临床怎么用

  • 作者认为,在解剖选择合适时,单枚IBD治疗孤立性髂总动脉瘤似乎是安全有效的治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We evaluated the short- and long-term results of off-label use of iliac branch devices (IBDs) in isolated common iliac artery aneurysms compared with the manufacturer-recommended configuration with additional extension in the infrarenal aorta based on the pELVIS Registry (pErformance of iLiac branch deVIces for aneurysmS involving the iliac bifurcation). METHODS: Between January 2005 and April 2017, 804 patients underwent endovascular aneurysm repair with 910 IBDs owing to aneurysmal involvement of the iliac bifurcation in nine high-volume European vascular centers. Among this cohort, 231 IBDs were implanted in 207 patients to treat an isolated common iliac aneurysm; 91 IBDs (group 1) were implanted without proximal aortic extension in the infrarenal aorta, and in the remaining cases (n = 140; group 2) an aortic bifurcated stent graft was deployed proximally as stated in the instructions for use. Primary outcomes were IBD and target hypogastric artery occlusions, type I and III endoleaks, procedure-related reinterventions, and aneurysm-related deaths. RESULTS: Technical success was achieved in 90 cases (98.9%) in group 1 versus 137 cases (97.8%) in group 2 (P = .55). The overall aneurysm-related early reintervention rate for the two groups was 4.4% (4 of 91) and 2.1% (3 of 140), respectively (P = .33). The 30-day mortality was 1.1% in group 1 (n = 1), and 0% in group 2 (P = .21). The median postoperative follow-up in groups 1 and 2 were 34.1 months (range, 1-108 months) and 17.5 months (range, 1-90 months), respectively. The estimated rates of freedom from IBD occlusion at 60 months were 86% in group 1 and 83% in group 2 (P = .69). The estimated rates of freedom from target hypogastric artery occlusion at 60 months were 98.3% in group 1 and 91.3% in group 2 (P = .45). The estimated freedom from reintervention rates at 60 months for types I, types III, and IBD stenosis-occlusion were 78.2% in group 1 and 79.9% in group 2 (P = .79). The estimated freedom from all cause reintervention at 60 months was 64.5% in group 1 and 66.1% in group 2 (P = .44). The estimated freedom from aneurysm-related death at 60 months was 97.9% in group 1 and 100% in group 2 (P = .83). CONCLUSIONS: Single IBD placement for isolated common iliac artery aneurysms seems to be a safe and effective treatment option, when a proper anatomic patient selection is provided. Major benefits are represented by the decrease in X ray exposure, overall procedural time, and use of contrast medium, without affecting perioperative and long-term results in comparison with more extensive procedures.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Fargion AT, Masciello F, Pratesi C, et al. Results of the multicenter pELVIS Registry for isolated common iliac aneurysms treated by the iliac branch device. J Vasc Surg. 2018. PMID: 30072046. doi:10.1016/j.jvs.2018.02.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。